Erratum: Pharmacology and molecular mechanisms of clinically relevant estrogen estetrol and estrogen mimic BMI-135 for the treatment of endocrine-resistant breast cancer (Molecular Pharmacology (2020) 98 (364-381) DOI: 10.1124/molpharm.120.000054)

Balkees Abderrahman, P. Y. Maximov, R. F. Curpan, J. S. Hanspal, P. Fan, R. Xiong, D. A. Tonetti, G. R.J. Thatcher, V. C. Jordan

Research output: Contribution to journalComment/debatepeer-review

Abstract

The above article [Abderrahman B, Maximov PY, Curpan RF, Hanspal JS, Fan P, Xiong R, Tonetti DA, Thatcher GRJ, and Jordan VC (2020) Mol Pharmacol, 98: 364-381; DOI: Https:// doi.org/10.1124/molpharm.120.000054] was incorrectly identified as an emerging concepts article when the copyedited and formatted version went online. It is a regular article. The HTML and PDF versions have been corrected. The compositor apologizes for any inconvenience caused by this error.

Original languageEnglish (US)
Pages (from-to)528
Number of pages1
JournalMolecular Pharmacology
Volume98
Issue number4
DOIs
StatePublished - Oct 2020

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Fingerprint

Dive into the research topics of 'Erratum: Pharmacology and molecular mechanisms of clinically relevant estrogen estetrol and estrogen mimic BMI-135 for the treatment of endocrine-resistant breast cancer (Molecular Pharmacology (2020) 98 (364-381) DOI: 10.1124/molpharm.120.000054)'. Together they form a unique fingerprint.

Cite this